FDA product code QFK: Tumor Gene Profiling Test

QFK is the FDA product code for tumor gene profiling test. It is a Not classified device, reviewed by the Pathology panel. Devices under QFK reach the market by Contact FDA; FDA lists no cleared 510(k)s for it.

Definition

A next-generation sequencing based tumor profiling test is a qualitative in vitro diagnostic test intended to detect mutations in a broad panel of targeted genes that are somatically altered in malignant neoplasms from nucleic acids isolated from human clinical specimens obtained from patients diagnosed with malignant neoplasms using targeted next-generation sequencing.

Classification

FieldValue
Device nameTumor Gene Profiling Test
Device classNot classified
Review panelPA — Pathology
Medical specialtyUnknown
Premarket routeContact FDA

Recalls for QFK devices

FDA recall records list no recalls for product code QFK.

Frequently asked questions

What is FDA product code QFK?

QFK is the FDA product code for tumor gene profiling test. It is a Not classified device, reviewed by the Pathology panel.

What device class is QFK?

Not classified. Typical premarket route: Contact FDA.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Pathology product codes · FDA product code lookup · 510(k) database search · 510(k) review times